Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Targeting of Cancer-Associated Fibroblasts in the Non-Small Cell Lung Cancer Tumor Microenvironment
Yasushi Shintani, Tōru Kimura, Soichiro Funaki, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 335-335
Open Access | Times Cited: 20

Showing 20 citing articles:

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 16
AI‐guided histopathology predicts brain metastasis in lung cancer patients
Haowen Zhou, Mark A. Watson, Cory T. Bernadt, et al.
The Journal of Pathology (2024) Vol. 263, Iss. 1, pp. 89-98
Open Access | Times Cited: 9
Vascularized tissue on mesh-assisted platform (VT-MAP): a novel approach for diverse organoid size culture and tailored cancer drug response analysis
Jungseub Lee, Sangmin Jung, Hye Kyoung Hong, et al.
Lab on a Chip (2024) Vol. 24, Iss. 8, pp. 2208-2223
Open Access | Times Cited: 7
Astrocyte plasticity shapes brain metastasis progression through tumor-astrocyte crosstalk
Rupleen Kaur, Nalin Gupta, Andrew Dhawan
(2025), pp. 1-15
Open Access
Targeting the Tumor Microenvironment in EGFR-Mutant Lung Cancer: Opportunities and Challenges
Jeong Uk Lim, Junyang Jung, Yeon Wook Kim, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 470-470
Open Access
Oncogenic Mutations and the Tumor Microenvironment: Drivers of Non-Small Cell Lung Cancer Progression
Achilleas Mitrakas, Christos Kakouratos, Ioannis Lamprou, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 853-853
Open Access
Advances in nanotechnology for targeting cancer-associated fibroblasts: A review of multi-strategy drug delivery and preclinical insights
Zhongsong Zhang, Yujie Tang, Dan Luo, et al.
APL Bioengineering (2025) Vol. 9, Iss. 1
Open Access
Comprehensive Analysis of Lung Adenocarcinoma and Brain Metastasis through Integrated Single-Cell Transcriptomics
Vanessa G. P. Souza, Nikita Telkar, Wan L. Lam, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3779-3779
Open Access | Times Cited: 2
Biophysical perspectives to understanding cancer-associated fibroblasts
Somayadineshraj Devarasou, Minwoo Kang, Jennifer H. Shin
APL Bioengineering (2024) Vol. 8, Iss. 2
Open Access | Times Cited: 2
A functional interplay between non-coding RNAs and cancer-associated fibroblasts in breast cancer
Sara Anajafi, Razie Hadavi, Seyede Maryam Valizadeh-Otaghsara, et al.
Gene Reports (2024) Vol. 36, pp. 101990-101990
Closed Access | Times Cited: 2
Tumor Microenvironment Heterogeneity, Potential Therapeutic Avenues, and Emerging Therapies
Xintong Peng, Jingfan Zheng, Tianzi Liu, et al.
Current Cancer Drug Targets (2023) Vol. 24, Iss. 3, pp. 288-307
Closed Access | Times Cited: 4
Exosomal ITGB6 from dormant lung adenocarcinoma cells activates cancer-associated fibroblasts by KLF10 positive feedback loop and the TGF-β pathway
Feng Xiang, Xianling Liu, Juanjuan Xiang, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 12, pp. 2520-2537
Open Access | Times Cited: 4
Paracrine Regulation and Immune System Pathways in the Inflammatory Tumor Microenvironment of Lung Cancer: Insights into Oncogenesis and Immunotherapeutic Strategies
Firas Batrash, Adnan Shaik, Rayaan Rauf, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1113-1113
Open Access | Times Cited: 1
Boosting immune responses in lung tumor immune microenvironment: A comprehensive review of strategies and adjuvants
Fei Gao, Xiaoqing You, Liu Yang, et al.
International Reviews of Immunology (2024) Vol. 43, Iss. 5, pp. 280-308
Closed Access | Times Cited: 1
Innovative Therapeutic Delivery of Metastasis-Associated in Colon Cancer 1-Suppressing miRNA Using High Transmembrane 4 L6 Family Member 5-Targeting Exosomes in Colorectal Cancer Mouse Models
Byung Jo Choi, Dosang Lee, Jung Hyun Park, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9232-9232
Open Access | Times Cited: 1
Predictors of lung cancer subtypes and lymph node status in non-small-cell lung cancer: intravoxel incoherent motion parameters and extracellular volume fraction
Huizhi Han, Wenxiu Guo, Hong Ren, et al.
Insights into Imaging (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
IL-17A-induced cancer-associated fibroblasts releases CXCL12 to promote lung adenocarcinoma progression via Wnt/β-Catenin signaling pathway
Xi'nan Lu, Xin Xu, Mengxue Zhou, et al.
Cytokine (2024) Vol. 180, pp. 156676-156676
Closed Access
The potential of tumour mechanotargeting in lung cancer therapeutics
Kostas A. Papavassiliou, Antonios N. Gargalionis, Athanasios G. Papavassiliou
Pulmonology (2024) Vol. 31, Iss. 1
Open Access
Cell Proteomic Footprinting: Advances in the Quality of Cellular and Cell-Derived Cancer Vaccines
Petr G. Lokhov, Elena E. Balashova, Oxana P. Trifonova, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 661-661
Open Access | Times Cited: 1
On Casein Kinase-2 (CK2) deregulation in NSCLC: an enzyme subunit-centered approach
George Perez, Li Chen, Deng Chenyi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top